A novel protease processing site in the transframe protein of human T-cell leukemia virus type 1 PR76gag-pro defines the N terminus of RT

Journal of Virology

Volumn 76, Issue 24, 2002, Pages 13101-13105

  Heidecker, Gisela ^a   Hill, Shawn ^a   Lloyd, Patricia A ^b   Derse, David ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; POL PROTEIN; POLYPROTEIN; PROLINE; PROTEINASE; RNA DIRECTED DNA POLYMERASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENETIC ANALYSIS; HUMAN T CELL LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ASPARTIC ENDOPEPTIDASES; BASE SEQUENCE; GENE PRODUCTS, GAG; HUMAN T-LYMPHOTROPIC VIRUS 1; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN PRECURSORS; RNA-DIRECTED DNA POLYMERASE;

EID: 0036891892     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.24.13101-13105.2002     Document Type: Article

References (18)

1. Agbuya, P. G., N. E. Sherman, and L. K. Moen. 2001. Proteolytic processing of the human T-cell lymphotropic virus 1 reverse transcriptase: Identification of the N-terminal cleavage site by mass spectrometry. Arch. Biochem. Biophys. 392:93-102.
2. Bartoe, J. T., B. Albrecht, N. D. Collins, M. D. Robek, L. Ratner, P. L. Green, and M. D. Lairmore. 2000. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J. Virol. 74:1094-1100.
3. Collins, N. D., G. C. Newbound, B. Albrecht, J. L. Beard, L. Ratner, and M. D. Lairmore. 1998. Selective ablation of human T-cell lymphotropic virus type 1 p121 reduces viral infectivity in vivo. Blood 91:4701-4707.
4. Copeland, K. F., A. G. Haaksma, D. Derse, and J. L. Heeney. 1994. Detection of human T-cell leukaemia virus 1 permissive cells using cell lines producing selectable recombinant virions. J. Virol. Methods 50:219-225.
5. Daenke, S., H. J. Schramm, and C. R. Bangham. 1994. Analysis of substrate cleavage by recombinant protease of human T cell leukaemia virus type 1 reveals preferences and specificity of binding. J. Gen. Virol. 75:2233-2239.
6. Derse, D., S. A. Hill, P. A. Lloyd, H. K. Chung, and B. A. Morse. 2001. Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors. J. Virol. Methods 75:8461-8468.
7. Derse, D., J. Mikovits, and F. Ruscetti. 1997. X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro. Virology 237:123-128.
8. Derse, D., J. Mikovits, D. Waters, S. Brining, and F. Ruscetti. 1996. Examining the molecular genetics of HTLV-I with an infectious molecular clone of the virus and permissive cell culture systems. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12:1-5.
9. Ding, Y. S., D. H. Rich, and R. A. Ikeda. 1998. Substrates and inhibitors of human T-cell leukemia virus type I protease. Biochemistry 37:17514-17518.
10. Gessain, A., F. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. de The. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii:407-410.
11. Hayakawa, T., Y. Misumi, M. Kobayashi, Y. Yamamoto, and Y. Fujisawa. 1992. Requirement of N- and C-terminal regions for enzymatic activity of human T-cell leukemia virus type I protease. Eur. J. Biochem. 206:919-925.
12. Kobayashi, M., Y. Ohi, T. Asano, T. Hayakawa, K. Kato, A. Kakinuma, and M. Hatanaka. 1991. Purification and characterization of human T-cell leukemia virus type I protease produced in Escherichia coli. FEBS Lett. 293:106-110.
13. Louis, J. M., S. Oroszlan, and J. Tozser. 1999. Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase. J. Biol. Chem. 274:6660-6666.
14. Osame, M., K. Usuku, S. Izumo, N. Ijichi, H. Amitani, A. Igata, M. Matsumoto, and M. Tara. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet i:1031-1032.
15. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415-7419.
16. Tozser, J., G. Zahuczky, P. Bagossi, J. M. Louis, T. D. Copeland, S. Oroszlan, R. W. Harrison, and I. T. Weber. 2000. Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases. Eur. J, Biochem. 267:6287-6295.
17. Trentin, B., N. Rebeyrotte, and R. Z. Mamoun. 1998. Human T-cell leukemia virus type 1 reverse transcriptase (RT) originates from thepro andpol open reading frames and requires the presence of RT-RNase H (RH) and RT-RH-integrase proteins for its activity. J. Virol. 72:6504-6510.
18. Yoshida, M., I. Miyoshi, and Y. Hinuma. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA 79:2031-2035.